Fluorinated ketene dithioacetals. Part 10. Synthesis of new perfluorinated (2H)-pyridazin-3-ones and 3-(alkyl- or arylamino) substituted pyridazines

Synthesis

Volumn , Issue 3, 2003, Pages 436-442

  Brulé, Cédric ^a   Bouillon, Jean Philippe ^a   Nicolaï, Eric ^b   Portella, Charles ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b CEREP   (France)

Author keywords

(2H) pyridazin 3 one; Fluorine; Nitrogen heterocycles; Pyridazine

Indexed keywords

AMINES; CHLORINATION; DEHYDROGENATION; KETONES; SYNTHESIS (CHEMICAL);

FLUORINATION;

ESTERS;

4 TETRAFLUOROETHYLPYRIDAZIN 3 ONE; ACETAL DERIVATIVE; KETENE DERIVATIVE; PERFLUORO COMPOUND; PYRIDAZIN 3 ONE; PYRIDAZINONE DERIVATIVE; THIOESTER; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHLORINATION; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ELIMINATION REACTION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLYMERIZATION; SUBSTITUTION REACTION;

EID: 0037233836     PISSN: 00397881     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-37350     Document Type: Article

References (24)

1. (a) Steiner, G.; Gries, J.; Lenke, D. J. Med. Chem. 1981, 24, 59.
2. (b) Wermuth, C. G.; Bourguignon, J. J.; Hoffmann, R.; Boigegrain, R.; Brodin, R.; Kan, J. P.; Soubrié, P. Bioorg. Med. Chem. Lett. 1992, 2, 833.
3. (c) Wermuth, C. G. Farmaco 1993, 48, 253.
4. (d) Contreras, J. M.; Rival, Y. M.; Chayer, S.; Bourguignon, J. J.; Wermuth, C. G. J. Med. Chem. 1999, 42, 730.
5. (a) Curran, W. C.; Ross, A. J. Med. Chem. 1974, 17, 273.
6. (b) Sircar, I.; Bobowski, G.; Bristol, J. A.; Weishaar, R. E.; Evans, D. B. J. Med. Chem. 1986, 29, 261.
7. Albright, J. D.; Moran, D. B.; Wright, W. B.; Collins, J. B.; Beer, B.; Lippa, A. S.; Greenblatt, E. N. J. Med. Chem. 1981, 24, 592.
8. (a) Breukelman, S. P.; Meakins, G. D.; Roe, A. M. J. Chem. Soc., Perkin Trans. 1 1985, 1627.
9. (b) Reddy, R. S.; Saravanan, K.; Kumar, P. Tetrahedron 1998, 54, 6553.
10. Huot, J.-F.; Muzard, M.; Portella, C. Synlett 1995, 247.
11. Hénin, B.; Huot, J.-F.; Portella, C. J. Fluorine Chem. 2001, 107, 281.
12. Bouillon, J.-P.; Hénin, B.; Huot, J.-F.; Portella, C. Eur. J. Org. Chem. 2002, 1556.
13. (a) Biomedicinal Aspects of Fluorine Compounds; Filler, R.; Kobayashi, Y., Eds.; Elsevier: New York, 1982.
14. (b) Welch, J. T. Tetrahedron 1987, 43, 3123.
15. (c) Fluorine in Bioorganic Chemistry; Welch, J. T.; Eswarakrishnan, S., Eds.; John Wiley & Sons: New York, 1991.
16. (a) Hewitt, C. D.; Silvester, M. J. Aldrichimica Acta 1988, 21, 3.
17. (b) Differding, E.; Frick, W.; Lang, R. W.; Martin, P.; Schmit, C.; Veenstra, S.; Greuter, H. Bull. Soc. Chim. Belg. 1990, 99, 647.
18. (c) Silvester, M. J. Aldrichimica Acta 1991, 24, 31.
19. (d) Silvester, M. J. Aldrichimica Acta 1995, 28, 45.
20. Ates, C.; Janousek, Z.; Viehe, H. G. Tetrahedron Lett. 1993, 34, 5711.
21. Csende, F.; Szabo, Z.; Bernath, G.; Stajer, G. Synthesis 1995, 1240.
22. Compound 4b was prepared according to the same procedure described for γ-keto thiolesters 4a, see ref. 7.
23. Bouillon, J.-P.; Didier, B.; Dondy, B.; Doussot, P.; Plantier-Royon, R.; Portella, C. Eur. J. Org. Chem. 2001, 187.
24. Muzard, M.; Portella, C. J. Org. Chem. 1993, 58, 29.